Brain Waste-Clearance System Scans Could Predict Epilepsy Surgery Success

For the roughly one in three people with epilepsy whose seizures refuse to yield to medication, surgery offers the most realistic chance of a cure. Yet even in the best surgical programs, a meaningful fraction of patients wake up from the operation and continue to seize. Clinicians have long searched for a preoperative signal, something measurable on a scan that separates the future seizure-free from the future non-seizure-free. A new study published in BMC Medicine suggests that the answer may lie in one of neuroscience’s most unexpected frontiers: the brain’s waste-clearance plumbing, a system known as the glymphatic system.

The research, led by Guixian Tang and Chunyuan Zeng of the First Affiliated Hospital of Jinan University together with colleagues at Guangdong 999 Brain Hospital, examined 123 patients with drug-resistant temporal lobe epilepsy and 48 healthy controls. Every participant underwent preoperative magnetic resonance imaging with diffusion tensor imaging, as well as fluorodeoxyglucose positron emission tomography, which maps how avidly different brain regions consume glucose. The team then tracked each patient’s postoperative seizure outcome using the standard Engel classification, dividing the cohort into 83 patients who became completely seizure-free and 40 who continued to experience seizures after surgery.

The glymphatic system, first described in the early 2010s, is a network of channels that run alongside blood vessels, the perivascular spaces, through which cerebrospinal fluid flushes metabolic waste out of brain tissue, most vigorously during sleep. Because these channels are far too small to image directly in living humans, researchers rely on indirect proxies. The most popular is the diffusion tensor imaging analysis along the perivascular space, or DTI-ALPS index. It exploits the fact that water molecules diffuse more freely along the perivascular channels than across them; when those channels become clogged or degraded, the directional asymmetry of water diffusion diminishes, and the ALPS index falls.

When the team compared ALPS values across the three groups, a clear gradient emerged. Both patient groups showed lower ALPS indexes on the side of the brain harboring the epileptic focus, and in overall mean values, than the healthy controls. More strikingly, the seizure-free patients sat in between: healthy controls scored highest, seizure-free patients intermediate, and non-seizure-free patients lowest. In other words, the worse the glymphatic clearance capacity before surgery, the bleaker the prognosis after it. The ipsilateral and mean ALPS indexes declined progressively across the groups in a statistically significant manner, hinting that glymphatic health is not merely a byproduct of having epilepsy but a marker of how severely the disease has disrupted the brain’s housekeeping machinery.

What makes the study genuinely novel, however, is not the ALPS comparison itself but the way the researchers coupled glymphatic measurements to brain metabolism. Glucose is the brain’s principal fuel, and FDG-PET reveals where that fuel is being burned, region by region, expressed as a standardized uptake value ratio. In patients destined for seizure freedom, the ipsilateral ALPS index correlated with the metabolic activity of multiple discrete brain regions, with the associated hypometabolic areas localized to the frontal lobe and cingulate cortex on the same side as the epileptic focus. These correlations survived stringent statistical correction for multiple comparisons, with voxel-level thresholds set at a corrected significance level below 0.005 and cluster-level significance below 0.05.

In the patients who failed to achieve seizure freedom, the picture changed dramatically. There, the ipsilateral ALPS index no longer tracked regional glucose uptake in any meaningful way. Instead, it correlated with parameters describing the architecture of the brain’s entire metabolic network: the characteristic path length, a measure of how many steps information or influence must traverse across the network; the global efficiency, which quantifies how well the network as a whole integrates information; and a related network measure denoted lambda. The correlations were modest in magnitude but statistically significant, with correlation coefficients ranging from about negative 0.37 to positive 0.38 and p-values between 0.016 and 0.023.

This divergence is the conceptual heart of the paper. The seizure-free patients displayed what the authors call preserved glymphatic-metabolic coupling: the waste-clearance system and the brain’s energy consumption remained locally synchronized, with cleaner-clearing brains showing coherent, regionally specific metabolic patterns. The non-seizure-free patients, by contrast, showed a breakdown of that local coupling and a shift toward network-level covariance, in which glymphatic function was entangled with the global organization of metabolism rather than with any particular region. The authors interpret this shift as a sign of deeper, system-wide disruption, one that a focal resection of the epileptic temporal lobe cannot fully repair.

Curiously, the raw metabolic measurements themselves told a subtler story. When the researchers compared standardized uptake value ratios and metabolic network parameters directly between the seizure-free and non-seizure-free groups, they found no significant differences. The prognostic information was not in any single number but in the relationship between two numbers, in how the glymphatic index and the metabolic data moved together or failed to. This is a recurring lesson in modern neuroimaging: the most informative features are often not the measurements themselves but their correlations, covariances, and network signatures, which capture how brain systems interact rather than how they behave in isolation.

The clinical implications are potentially significant. Epilepsy surgery is irreversible, removing or disconnecting brain tissue in the hope of ending seizures, and patients and families weigh the decision carefully. A preoperative imaging marker that stratifies surgical prognosis could refine patient counseling, sharpen the selection of surgical candidates, and perhaps motivate more extensive or alternative interventions in patients whose glymphatic-metabolic profiles look unfavorable. Because the DTI-ALPS index requires only a standard diffusion MRI sequence already acquired in most presurgical evaluations, adding it to the clinical workup would demand no new hardware, no radioactive tracers beyond those already used, and no additional scanning sessions.

As with any retrospective single-center study, caveats apply. The findings establish correlation, not causation; a low ALPS index does not itself cause poor surgical outcomes, and the mechanisms linking waste clearance to seizure recurrence remain speculative. The ALPS index is also sensitive to imaging parameters, head motion, and anatomical variability, and the field is still standardizing how it should be measured and interpreted. The authors themselves frame the result as evidence that glymphatic dysfunction carries preoperative prognostic value, a hypothesis that will need prospective validation in independent cohorts before it changes clinical practice. Still, the study opens an intriguing window: the brain’s nocturnal cleaning crew, long dismissed as plumbing trivia, may hold one of the keys to predicting which patients with drug-resistant temporal lobe epilepsy will finally live seizure-free.

Subject of Research: Glymphatic dysfunction and glucose metabolism as preoperative prognostic markers in drug-resistant temporal lobe epilepsy surgery

Article Title: Preoperative correlations between glymphatic function and glucose metabolism in drug-resistant temporal lobe epilepsy: divergent patterns and postoperative outcomes

Article References: Tang, G., Zeng, C., Cai, Q., Luo, J., Wu, B., Zhang, P., Tang, Y., Li, S., Gong, H., Jiang, Y., Wu, H., Chen, G., Guo, Q., Xu, H., & Ling, X. (2026). Preoperative correlations between glymphatic function and glucose metabolism in drug-resistant temporal lobe epilepsy: divergent patterns and postoperative outcomes. BMC Medicine. https://doi.org/10.1186/s12916-026-05243-7

Image Credits: AI Generated

DOI: 10.1186/s12916-026-05243-7

Keywords: temporal lobe epilepsy, glymphatic system, DTI-ALPS, FDG-PET, glucose metabolism, epilepsy surgery, surgical outcome, diffusion tensor imaging, metabolic network, seizure freedom, neuroimaging, drug-resistant epilepsy